If Trump wants to lower drug prices, his obvious free-riding targets are outside the US
The Trump administration has secured nine new pricing agreements with pharmaceutical manufacturers to reduce American drug costs. However, this opinion piece argues that the real issue driving high medicine prices is not domestic drug pricing but rather wealthy foreign governments using price controls and rebates to pay artificially low prices for American-developed medicines. The article…